Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study

BACKGROUND: The aim was to compare changes in HbA1c and body weight after initiation of dapagliflozin or basal insulin supported oral therapy (BOT) in type 2 diabetes patients in primary care practices. METHODS: Patients from 983 primary care practices who started dapagliflozin or BOT between Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostev, Karel, Pscherer, Stefan, Rist, Roland, Busch, Stefan, Scheerer, Markus F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505432/
https://www.ncbi.nlm.nih.gov/pubmed/28300454
http://dx.doi.org/10.1177/1932296816688011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505432/
https://www.ncbi.nlm.nih.gov/pubmed/28300454
http://dx.doi.org/10.1177/1932296816688011

Ejemplares similares